Keywords: Tumors (Post-Treatment), Tumors
Motivation: Existing MRI sequences like magnetization-prepared rapid gradient echo (MPRAGE) may not adequately detect small metastatic lesions, hindering accurate diagnosis and treatment planning.
Goal(s): Our goal was to compare the diagnostic performance of Dixon unbalanced T1 relaxation-enhanced steady-state (uT1RESS) with MPRAGE in patients with primary brain tumors and metastases at 3 Tesla.
Approach: A prospective, single-center study evaluated image quality and lesion characterization using both techniques.
Results: Dixon uT1RESS showed improved tumor-to-brain contrast and enhanced lesion visibility, particularly for small metastatic lesions, while maintaining high overall image quality. However, MPRAGE outperformed uT1RESS in assessing internal lesion structure.
Impact: Dixon uT1RESS significantly improved the detection of small metastatic lesions and evaluation of vascular and dural involvement compared to MPRAGE. It may enhance tumor management in brain metastasis patients, though additional sequences might be needed to fully characterize enhancing lesions.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords